Agilent Technologies Reports First-Quarter 2014 Results

Financial Statements Financial Tables (129KB)

Highlights: GAAP net income of $195 million, or $0.58 per share Non-GAAP net income of $226 million, or $0.67 per share(1) Orders of $1.68 billion and revenues of $1.68 billion Second-quarter fiscal year 2014 revenue guidance of $1.72 billion to $1.74 billion, and non-GAAP earnings guidance of $0.71 to $0.73 per share(2) Fiscal year 2014 revenue guidance of $6.90 billion to $7.10 billion. Non-GAAP earnings guidance at $2.96 to $3.16 per share(2) Announced Keysight Technologies as the name of the electronic measurement spinoff

SANTA CLARA, Calif., Feb 13, 2014

Agilent Technologies Inc. (NYSE: A) today reported orders of $1.68 billion, down 2 percent over one year ago, for the first fiscal quarter ended Jan. 31, 2014, and revenues of $1.68 billion, flat compared with one year ago. First-quarter GAAP net income was $195 million, or $0.58 per share. Last year’s first-quarter GAAP net income was $179 million, or $0.51 per share.

During the first quarter, Agilent had intangible amortization of $51 million, integration and transformation costs of $10 million, pre-separation costs of $20 million and a tax benefit of $47 million. Excluding these items and $3 million of other net benefits, Agilent reported first-quarter adjusted net income of $226 million, or $0.67 per share(1).

Agilent President and CEO Bill Sullivan said, "Our life sciences, diagnostics and applied market businesses got off to a solid start in the quarter. Electronic measurement, however, faced challenges in the aerospace/defense market. Our plans to separate into two companies are on track, and we expect the transaction to be completed in early November 2014."

Electronic Measurement first-quarter revenues were down 7 percent compared with the prior year. Operating margins were 15 percent.

Chemical Analysis revenues were up 6 percent compared with a year ago, driven by food and forensics markets. Operating margins were 23 percent.

Life Sciences and Diagnostics revenues were up 5 percent over a year ago, reflecting strength in pharma and diagnostics/clinical markets. Operating margins were 17 percent.

Agilent generated $194 million of cash from operations in the quarter. First-quarter ROIC was 15 percent(3).

Second-quarter 2014 revenues are expected to be in the range of $1.72 billion to $1.74 billion. Second-quarter non-GAAP earnings are expected to be in the range of $0.71 to $0.73 per share(2).

For the full fiscal year 2014, Agilent expects revenue of $6.90 billion to $7.10 billion and non-GAAP earnings of $2.96 to $3.16 per share(2).

 

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.

On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.

Agilent’s management will present more details about its first-quarter FY2014 financial results on a conference call with investors today at 1:30 p.m. PT. This event will be webcast live in listen-only mode. Listeners may log on atwww.investor.agilent.com and select "Q1 2014 Agilent Technologies Inc. Earnings Conference Call" in the "News & Events Calendar of Events" section. The webcast will remain available on the company’s website for 90 days.

Additional information regarding financial results can be found at www.investor.agilent.com by selecting "Financial Results" in the "Financial Information" section.

A telephone replay of the conference call will be available at 4:30 p.m. (Pacific Time) after the call through Feb. 20. The replay number is (855) 859-2056, or for international, dial (404) 537-3406; enter passcode 31478615.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent’s future revenues, earnings and profitability; the future demand for the company’s products and services; customer expectations; and revenue and non-GAAP earnings guidance for the second quarter and full fiscal year 2014. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of our customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; customer purchasing decisions and timing, and the risk that we are not able to realize the savings expected from integration and restructuring activities.

In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on our operations, our markets and our ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability of our supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended Oct. 31, 2013. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

(1) Non-GAAP net income and non-GAAP net income per share exclude primarily the impacts of acquisition and integration costs, pre-separation costs, transformation initiatives and restructuring costs, and non-cash intangibles amortization. We also exclude any tax benefits that are not directly related to ongoing operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. A reconciliation between non-GAAP net income and GAAP net income is set forth on page 5 of the attached tables along with additional information regarding the use of this non-GAAP measure.

(2) Non-GAAP earnings per share as projected for Q2FY14 and full fiscal year 2014 excludes primarily the impacts of acquisition and integration costs, pre-separation costs, future restructuring costs, asset impairment charges, and non-cash intangibles amortization. We also exclude any tax benefits that are not directly related to ongoing operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy. Therefore, no reconciliation to GAAP amounts has been provided. Future amortization of intangibles is expected to be approximately $50 million per quarter.

(3) Return on invested capital (ROIC) is a non-GAAP measure and is defined as income from operations less other (income) expense and taxes, annualized, divided by the average of the two most recent quarter-end balances of assets less net current liabilities. The reconciliation of ROIC can be found on page 7 of the attached tables, along with additional information regarding the use of this non-GAAP measure.